International Conference on

Hypertension

Hypertension 2021

Theme: Discovering the latest advancements in Hypertension

International Conference on Hypertension will be scheduled during November 17-18, 2021 in London, United Kingdom which includes stimulating keynote presentations, Oral talks, Workshops/Symposia, Poster presentations, and Exhibitions. The theme of the conference is around, “Discovering the latest advancements in Hypertension”. Hypertension 2021 is the outstanding event that brings the most professionals, experts, and researchers, both from academia and industry across the world to share their knowledge, expertise, and research views in this conference.
The meeting covers a large area of knowledge in the field not only of hypertension but also of other cardiovascular and metabolic disorders related to hypertension. We deem to pay particular attention to new technologies, such as innovative devices, new communicating tools, and biological research. The presence of opinion leaders and experts from all around the world shall ensure the success of the meeting. So there would be no reason for not joining the finest Cardiology Meeting ever.
We look forward to seeing you in London.

 

Session 1: Hypertension
Hypertension is a chronic disease. It can be controlled with medication, but it cannot be cured. Due to the lack of noticeable symptoms, hypertension is a silent health condition. The only way of knowing the problem is to check your blood pressure. Hence the patients need to continue with the treatment and lifestyle modifications as advised by their doctor, and attend regular medical follow up, usually for life. To examine current patterns of hypertension (HTN) treatment, including blood pressure (BP) control, prevalence of different antihypertensive agents, and variations in treatment associated with patient and physician characteristics. Hypertension Conference is covering the topics such as Secondary Hypertension, Hypertension Rheumatoid Arthritis, Oncology and Blood Pressure, Genetic Factors of Hypertension, Life Style of High Blood Pressure.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 2: Pulmonary & Arterial hypertension
Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. The most relevant mechanisms for sudden cardiac death in PAH patients seem to be related to severe dilatation of the pulmonary artery, as subsequent complications, such as left main compression syndrome, pulmonary artery dissection, pulmonary artery rupture, and massive hemoptysis, may take place.
An arterial high blood pressure has the characteristic of pressure indicators, either equal of higher than 140 mm Hg for the systolic or 90 mm Hg for the diastolic pressure, after having repeatedly measured the arterial tension. Essential arterial hypertension is one of the main treatable cardiovascular risk factors. It can be well controlled and the cardiovascular risk reduced through a combination of lifestyle interventions and first-line antihypertensive drugs.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 3: Pediatric Hypertension
In the pediatric population, hypertension is more commonly observed which is the major cause of mortality and morbidity in many countries.  And long-term health risk to children. It is also noted that there is a correlation between overweight obesity and hypertension and also blood pressure of parents and that of their offspring. Obese children have 3 fold risk of getting hypertension than that of no obese. Children with hypertension should also be screened for cardiovascular disease, including diabetes mellitus and hyperlipidaemia, and should be evaluated for target organ damage with a retinal examination and echocardiography.
The ambulatory blood pressure (ABP) measures used to classify pediatric hypertension and left ventricular mass index (LVMI) in children with true ambulatory hypertension. Pediatric idiopathic intracranial hypertension is a rare condition, but inappropriate diagnosis and management may lead to devastating outcome with loss of vision and lifelong handicap.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 4: Resistance Hypertension
Resistance hypertension is high blood pressure that does not respond well to aggressive medical treatment. It is defined as failure to achieve goal blood pressures in patients taking optimal or maximum tolerated doses of three or more antihypertensive drugs, is estimated to occur in about 25% of hypertensive patients on treatment. Several factors have been identified as contributors to resistant hypertension. Poor patient adherence, physician inertia, inadequate doses or inappropriate combinations of antihypertensive drugs, excess alcohol intake, and volume overload are some of the most common causes of resistance.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 5: Renal/ Renovascular Hypertension
Renal /Renovascular hypertension caused by a narrowing of the arteries which convey blood to the kidney and which can be controlled by circulatory strain drugs. Individuals with renal hypertension can benefit from outside assistance by stenting, angioplasty, or surgery on the veins of the kidney. Renal hypertension mirrors the connection between blood vessel occlusive sickness and hoisted pulse. More particular determinations are made reflectively when hypertension enhances after intravascular intercession. Renal Hypertension Conference will give the subject are Signs and Side effects of Renal Hypertension, Pathogenesis of Renal Hypertension., Determination and Treatment, Hazard Variables for Renal Hypertension, Renal-supply route Angioplasty and Stenting. High circulatory strain is mostly unsafe as the patients by and large don't encounter the manifestations, so organ harm can happen gradually without being recognized. chronic kidney maladies can be caused by Renal Hypertension .Different strategies have been created to analyse renal hypertension utilizing computerized picture preparing of radiographs.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 6: Gestational Hypertension
Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia in pregnancy. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20th week of pregnancy). The diagnosis is changed to, Preeclampsia, if proteinuria or new signs of end-organ dysfunction develop and chronic (primary or secondary) hypertension, if blood pressure elevation persists ≥12 weeks postpartum.
Gestational Hypertension Workshop related to the subjects are Classification of Pregnancy Induced Hypertension, Risk factors for Gestational Hypertension, Pre-eclampsia and Eclampsia, Pathogenesis of Pre-Eclampsia, Management of Hypertension in Pregnancy, Drug Treatment of Gestational Hypertension, Long Term Cardiovascular Sequelae of Gestational Hypertension.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 7: Heart & Cardiovascular diseases
All heart diseases are cardiovascular diseases, but not all cardiovascular diseases are heart disease. The most common type of heart disease is coronary heart disease. Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. The treatment for heart disease usually includes lifestyle changes.
Heart conditions caused by high blood pressure known as Hypertensive heart disease. Heart problems associated with high blood pressure related to the heart arteries and muscles include narrowing of the arteries called Coronary Heart Disease(CHD) and Thickening and enlargement of the heart called Left Ventricular Hypertrophy(LVH). Both CHD and LVH can lead to heart failure, arrhythmia, ischemia, heart disease, heart attack, sudden cardiac arrest, stroke and sudden death.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 8: Hypertension Diagnosis and Assessment
Diagnostic trials usually include people who have signs or symptoms of the disease or condition being studied. It refers to trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition.
Hypertension is difficult to manage as the patients are generally symptomless and treatment is preventative rather than palliative. The best way to diagnose hypertension is to measure your blood pressure. If blood pressure is 140/90 mmHg or higher then offer ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension. Treatment of hypertension is important for the prevention of cardiovascular and kidney diseases.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 9: Hypertension Management
Randomized controlled trials have shown that managing hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. Despite the inherent health risks associated with uncontrolled hypertension, elevated blood pressure remains inadequately treated in the majority of patients.
Treating high blood pressure includes diet changes, exercise, and medication. Changing lifestyle can lead to control high blood pressure.  The doctor may recommend for a healthy diet with less salt, regular exercise, quit smoking and maintain weight. But sometimes lifestyle changes aren't enough Some treatment and care for hypertension include High blood pressure drug supplement, calcium channel blockers ACE inhibitors, diuretics, beta blocker, omega-3 fish oil supplements etc.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 10: Prevalence and lifetime risk of hypertension
Hypertension is the major risk factor for cardiovascular disease stroke obesity. Lifetime risk estimates for disease condition are more easily understood by the general public compared with other measures of disease Hypertension is an important global health challenge due to its high prevalence and resulting cardiovascular disease and chronic kidney disease. The prevalence of hypertension is relatively very high. Hypertension Risk Factors Conference providing related topics are Controllable Risk Factors, Uncontrollable Risk Factors, Medical Risk Factors, Other Factors.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Session 11: Coronary Intervention in HTN
Hypertension is associated with increased mortality in patients with ischemic heart disease after revascularization with percutaneous coronary intervention. Hypertension is associated with higher mortality in patients with STEMI, NSTEMI/UA or stable angina who are treated with PCI. The outcome in patients undergoing percutaneous coronary intervention in relation to diabetes and hypertension.
People with high blood pressure are more likely to develop coronary artery disease, because high blood pressure puts added force against the artery walls. Over time, this extra pressure can damage the arteries, making them more vulnerable to the narrowing and plaque buildup associated with atherosclerosis.
Keywords: Hypertension Congress | Cardiology Congress | Hypertension Meetings | Cardiology Meetings | Hypertension Workshops | Cardiology Events  | Hypertension & Cardiology Conferences | Hypertension Conferences

Globally, Hypertension or high Blood Pressure leads to 7.5million death cases which shares about 12.8% of all death cases recorded. Hypertension is also accounts about 57million disabilities adjusted life years which is about 3.7% of total adjusted life years. Hypertension is the primary risk factor of coronary heart disease, ischemic & hemorrhagic stroke.
As per the research of some independent firm, global Hypertension drug market is estimated to be $24.7billion in 2018 & expected to hit about $19.3 billion by 2029 with an annual CAGR of -2.3% in between 2019 to 2029. As per the estimation of WHO, globally more than 1.13 billion of people are affected with Hypertension among which less than 1 in each 5 is under control. Unhealthy diets, lack of physical activities, consumption of alcohol & tobacco are the main contributing factors of Hypertension. To reduce the prevalence by 25% by 2025, WHO along with United States Center for Disease Control and Prevention launched Global heart Initiative in 2016.

Scope and Importance:
Hypertension is a significant public health concern of world-wide distribution and is also the most common cardiovascular disease risk factor. Hypertension or elevated blood pressure is a serious medical condition that significantly increases the risks of heart, brain, kidney and other diseases. An estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries. Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. Hypertension depends on the knowledge and aptitudes to Cardiology and Cardiac Care. The patients of all age groups can be affected.  Cardiologist and hypertension specialists treat a large number of patients and decide according to their conditions in most of the modern emergency situations. The scope study of this report includes a key market analysis, market drivers, industry constraints, competitive developments and market trends. Research analyses each market segment and its applications, regulatory environment, technology, market projections and market shares. A complete geographical analysis of the market is also presented in the report. The emerging market for cardiology and ambulatory includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. Profiles of key market players are also covered in this report.

Related Societies:
USA:
American College of Cardiology, American Society of Hypertension, American Society of Nephrology, Council for the High Blood Pressure Research of the AHA, The International Society of Hypertension, Abiomed, Alliance for Heart Failure, American Academy of Cardiovascular Perfusion, American Heart Association, American Society of Nuclear Cardiology, Association for Inherited Cardiac Conditions, Atrial Fibrillation Association, Heart and Stroke Foundation of Canada, Heart Failure Society of America, University of Ottawa Heart Institute, Heart Rhythm Society, Heart Support of America, Interamerican Society of Cardiology, Canadian Cardiovascular Society, Congenital Heart Surgeons' Society, Mended Hearts, Society for Cardiovascular Magnetic Resonance, The Texas Heart Institute.

EUROPE:
European Association for Cardio-Thoracic Surgery, European Society of Cardiology, Heart Research UK, Resuscitation Council (UK), Blood Pressure Association, British Cardiovascular Society, British Heart Foundation, Cardiac Risk in the Young, Deutsche Gesellschaft für Kardiologie, GISSI, Heart and Diabetes Center North Rhine-Westphalia, Heart Institute, University of São Paulo, Institute of Cardiovascular & Medical Sciences, Libin Cardiovascular Institute of Alberta, Lourdes Heart Institute, Montreal Heart Institute, Montreal Heart Institute Foundation, Mount Sinai Medical Center (Miami), National Heart Forum, National Heart Foundation of New Zealand, Surgeons of Hope, Tiny Tickers, West of Scotland Heart and Lung Centre.

MIDDLE EAST REGIONS:
Cardiovascular System Dynamics Society, Corindus Vascular Robotics, Heart and Diabetes Center North Rhine-Westphalia, Heart Research Institute, National Heart Foundation, National Heart Institute, Philippine Heart Center, Tanzania Heart Institute, Uganda Heart Institute, Victor Chang Cardiac Research Institute, UAE Cardiology heart forum, Egyptian Society of Cardiology, Emirates Cardiac Society, Gulf Heart Association, Saudi Arabia Cardiology society, Heart Valve Society, Society of Cardiovascular Magnetic Resonance, Saudi Heart Association.

ASIA-PACIFIC REGIONS:
International Society for Heart Research, Krishna Heart Institute, National Heart Foundation (Bangladesh), National Heart Foundation of Australia, Rabindranath Tagore International Institute of Cardiac Sciences, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Multan Institute of Cardiology, Asian Pacific Society of Cardiology, Asian Pacific Society of Interventional Cardiology. Asia Pacific Heart Rhythm Society (APHRS), Asian Pacific Society of Cardiology, Asean Federation Of Cardiology, Asia-Pacific pediatric cardiac society, Taiwan Society of Cardiology, Association of Physician Assistants in Cardiology.

Why London?
London is the capital and most-populous city of United Kingdom. London City in England is called “The Smoke” or “The Big Smoke”. London is a city of dreams. It is a city of unbearable amazing fashion and up and coming new talents from the entire globe. London is among the world's leading commercial, financial, and cultural centers. Other major cities include Birmingham, Liverpool, and Manchester in England, Belfast and Londonderry in Northern Ireland, Edinburgh and Glasgow in Scotland, and Swansea and Cardiff in Wales. London is the global city and financial center with an urban area population of 10.3 million. The United Kingdom consists of four countries: - England, Scotland, Wales and Northern Ireland. Their capitals are London, Edinburgh, Cardiff and Belfast, respectively.

Universities in USA:

Universities in Europe:

Universities in Asia:

Universities in Middle East:

Top Cardiology Hospitals in the World:

Conclusion:
Hypertension is a very important disorder in aged people and is associated with higher risk of cardiovascular morbidity and mortality. The fact of reducing blood pressure values decreases the risk for cardiac death as well as neurological, metabolic, and musculoskeletal system sequelae in aged people. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. The best way to help prevent a stroke is to eat a healthy diet, exercise regularly, and avoid smoking and drinking too much alcohol. These lifestyle changes can reduce your risk of problems like: arteries becoming clogged with fatty substances (atherosclerosis) high blood pressure.

Meetings International is a global leader in organizing conferences and workshops in all major fields of science, technology and medicine. Meetings International websites are being visited by doctors, engineers, young and budding researchers, entrepreneurs, eminent scientists, academicians and Nobel laureates from various sectors of medical and non-medical sciences. We can target impressions of your advertisements by conferences subject or region and report results in comprehensive detail.
Hypertension 2021 attracts different companies and startup businesses to digitally advertise their products and services on its web platform which will help in informing customers quickly and efficiently. The quality and diversity of our advertising options provide clients with the very best customized marketing opportunities. Our advertising platform will provide you is the best chance of showcasing your products/services, and branding your company.
Bring your product to life and create instant brand awareness with a banner ad placement. Make your banner interactive to direct people to where you want them to go. We offer banner ads on our website which will be beneficial for life science professionals across the globe.
Our subscribers and conference attendees can be your upcoming enthusiastic customers. Here is your opportunity to advertise in the website that can connect you to leading experts and specialists worldwide.
Advertisement banner should be provided by the advertising company and must be in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
Any queries regarding advertising opportunities, please contact our representative: contact@meetingsint.com

Meetings International is announcing Young Scientist Awards through “International Conference on Hypertension” (Hypertension 2021) which is scheduled in London, UK during November 17-18, 2021. This Hypertension 2021 focuses on “Discovering the latest advancements in Hypertension”. Hypertension 2021 and upcoming conferences will recognize participants who have significantly added value to the scientific community of Hypertension and provide them outstanding Young Scientist Awards.
The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences. Hypertension 2021 aims on the level of thought that individual patients need at various centers in their course. Clinical decision guidelines are generally perceived as best practice for an inexorably normal nearness in the biomedical composition. Hypertension conference organizing committee conference is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.

Eligibility: Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance: To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.

Award Announcements: Official announcement of the recipients will occur after the completion of Hypertension Conference.

Meetings International has always been at the forefront to support and encourage the scientific and techno researchers to march forward with their research work. Hypertension 2021 conference offers various awards as reorganization to exceptional researcher and their research work. We invite all enthusiastic researchers from all around the world join us for the International Conference on Hypertension scheduled in London, UK during November 17-18, 2021.

Eminent Key Note Speaker Award:
Hypertension 2021 will confer the Model Key Note Speaker Award to the researchers who have spent a considerable time of their academic life towards the research related to conference topic. Key note speaker award is for the researchers/speakers who have done all the hard work behind the scene. It will be a small clap for their dedication and hard work.   

Outstanding Speaker Award:
Hypertension 2021 will bestow model speaker award to those researchers who have made significant contribution towards the conference topic during their research period as well as presented the research topic in an impressive way in the oral presentation during the summit. It will be an apt appreciation from the Jury as well as from the delegates. The award they receive will motivate them to march forward with the research work.   

Model Organizing Committee Member Award:
Hypertension 2021 will take this opportunity to facilitate eminent experts from this field with the model Organizing Committee Member award for their phenomenal contribution towards the society through their academic research.  This will be a trivial but significant reorganization of their dedication and discipline.   

Promising Young Researcher Award:
The motive of this Award during the Hypertension 2021 is to appreciate research work of the budding young researcher who is continuing their research work to create a better society. The award will provide them a tremendous amount of encouragement to keep moving forward.   

Educative Poster Award:
The educative poster award for the Hypertension 2021   will be endorsement for those who wishes to display their research paper through a poster and will act as a guiding force those researchers. The award will be presented to the most informative and educative research poster.   

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue.
  • All the awards will be selected by the judges of the award category.
  • The winners will be formally announced during the closing ceremony.
  • The winners of the Poster Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference.
  • Each individual participant is allowed to submit maximum 2 papers.
  • Abstract must be submitted online as per the given abstract template.
  • Abstracts must be written in Times New Roman and font size will be 12.
  • Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.
  • Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.
  • Hypertension
  • Pulmonary & Arterial hypertension
  • Pediatric Hypertension
  • Resistance Hypertension
  • Renal/ Renovascular Hypertension
  • Gestational Hypertension
  • Heart & Cardiovascular diseases
  • Hypertension Diagnosis and Assessment
  • Hypertension Management
  • Prevalence and lifetime risk of hypertension
  • Coronary Intervention in HTN

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner